{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:12:02Z","timestamp":1782796322299,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Suzhou Medical Treatment and Public Health Foundation","award":["SKJY2021030"],"award-info":[{"award-number":["SKJY2021030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Chronic kidney disease-mineral and bone disorder (CKD-MBD) is characterized by bone abnormalities, vascular calcification, and some other complications. Although there are diagnostic criteria for CKD-MBD, in situations when conducting target feature examining are unavailable, there is a need to investigate and discover alternative biochemical criteria that are easy to obtain. Moreover, studying the correlations between the newly discovered biomarkers and the existing ones may provide insights into the underlying molecular mechanisms of CKD-MBD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We collected a cohort of 116 individuals, consisting of three subtypes of CKD-MBD: calcium abnormality, phosphorus abnormality, and PTH abnormality. To identify the best biomarker panel for discrimination, we conducted six machine learning prediction methods and employed a sequential forward feature selection approach for each subtype. Additionally, we collected a separate prospective cohort of 114 samples to validate the discriminative power of the trained prediction models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Using machine learning under cross validation setting, the feature selection method selected a concise biomarker panel for each CKD-MBD subtype as well as for the general one. Using the consensus of these features, best area under ROC curve reached up to 0.95 for the training dataset and 0.74 for the perspective dataset, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion\/Conclusion<\/jats:title>\n                <jats:p>For the first time, we utilized machine learning methods to analyze biochemical criteria associated with CKD-MBD. Our aim was to identify alternative biomarkers that could serve not only as early detection indicators for CKD-MBD, but also as potential candidates for studying the underlying molecular mechanisms of the condition.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12911-024-02421-6","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T11:05:08Z","timestamp":1707131108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Machine learning based biomarker discovery for chronic kidney disease\u2013mineral and bone disorder (CKD-MBD)"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukuan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaixin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,5]]},"reference":[{"issue":"11","key":"2421_CR1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2006;69(11):1945\u201353.","journal-title":"Kidney Int"},{"key":"2421_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2147\/IJNRD.S191156","volume":"12","author":"B Waziri","year":"2019","unstructured":"Waziri B, Duarte R, Naicker S. Chronic kidney Disease-Mineral and Bone Disorder (CKD-MBD): current perspectives. Int J Nephrol Renovasc Dis. 2019;12:263\u201376.","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"2421_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","volume":"100","author":"KA Hruska","year":"2017","unstructured":"Hruska KA, Sugatani T, Agapova O, Fang Y. The chronic kidney disease - Mineral bone disorder (CKD-MBD): advances in pathophysiology. Bone. 2017;100:80\u20136.","journal-title":"Bone"},{"issue":"6","key":"2421_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.semnephrol.2014.09.006","volume":"34","author":"S Mazzaferro","year":"2014","unstructured":"Mazzaferro S, Tartaglione L, Rotondi S, Bover J, Goldsmith D, Pasquali M. News on biomarkers in CKD-MBD. Semin Nephrol. 2014;34(6):598\u2013611.","journal-title":"Semin Nephrol"},{"issue":"2","key":"2421_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.semnephrol.2014.02.007","volume":"34","author":"P Evenepoel","year":"2014","unstructured":"Evenepoel P, Rodriguez M, Ketteler M. Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease? Semin Nephrol. 2014;34(2):151\u201363.","journal-title":"Semin Nephrol"},{"issue":"2","key":"2421_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/07853890701689645","volume":"40","author":"KY Renkema","year":"2008","unstructured":"Renkema KY, Alexander RT, Bindels RJ, Hoenderop JG. Calcium and phosphate homeostasis: concerted interplay of new regulators. Ann Med. 2008;40(2):82\u201391.","journal-title":"Ann Med"},{"issue":"1","key":"2421_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/ndt\/gfi268","volume":"21","author":"P Houillier","year":"2006","unstructured":"Houillier P, Froissart M, Maruani G, Blanchard A. What serum calcium can tell us and what it can\u2019t. Nephrol Dial Transplant. 2006;21(1):29\u201332.","journal-title":"Nephrol Dial Transplant"},{"issue":"20","key":"2421_CR8","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","volume":"342","author":"WG Goodman","year":"2000","unstructured":"Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342(20):1478\u201383.","journal-title":"N Engl J Med"},{"issue":"8","key":"2421_CR9","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8):2208\u201318.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2421_CR10","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","volume":"26","author":"J Floege","year":"2011","unstructured":"Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant. 2011;26(6):1948\u201355.","journal-title":"Nephrol Dial Transplant"},{"issue":"27","key":"2421_CR11","doi-asserted-by":"publisher","first-page":"7882","DOI":"10.1002\/anie.201503065","volume":"54","author":"M Arrowsmith","year":"2015","unstructured":"Arrowsmith M, Hill MS, Johnson AL, Kociok-Kohn G, Mahon MF. Attenuated Organomagnesium activation of White Phosphorus. Angew Chem Int Ed Engl. 2015;54(27):7882\u20135.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"5","key":"2421_CR12","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/ki.2013.21","volume":"83","author":"P Evenepoel","year":"2013","unstructured":"Evenepoel P, Wolf M. A balanced view of calcium and phosphate homeostasis in chronic kidney disease. Kidney Int. 2013;83(5):789\u201391.","journal-title":"Kidney Int"},{"issue":"7","key":"2421_CR13","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","volume":"87","author":"S Jono","year":"2000","unstructured":"Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87(7):E10\u20137.","journal-title":"Circ Res"},{"issue":"9","key":"2421_CR14","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/ki.2008.644","volume":"75","author":"CM Giachelli","year":"2009","unstructured":"Giachelli CM. The emerging role of phosphate in vascular calcification. Kidney Int. 2009;75(9):890\u20137.","journal-title":"Kidney Int"},{"issue":"5","key":"2421_CR15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1161\/ATVBAHA.108.183384","volume":"29","author":"R Villa-Bellosta","year":"2009","unstructured":"Villa-Bellosta R, Sorribas V. Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition. Arterioscler Thromb Vasc Biol. 2009;29(5):761\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"2421_CR16","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/ki.2011.18","volume":"79","author":"MM Zhao","year":"2011","unstructured":"Zhao MM, Xu MJ, Cai Y, Zhao G, Guan Y, Kong W, et al. Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo. Kidney Int. 2011;79(10):1071\u20139.","journal-title":"Kidney Int"},{"issue":"5","key":"2421_CR17","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1161\/CIRCRESAHA.108.181305","volume":"103","author":"AE Ewence","year":"2008","unstructured":"Ewence AE, Bootman M, Roderick HL, Skepper JN, McCarthy G, Epple M, et al. Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ Res. 2008;103(5):e28\u201334.","journal-title":"Circ Res"},{"issue":"2","key":"2421_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1053\/j.ackd.2010.12.002","volume":"18","author":"WL Lau","year":"2011","unstructured":"Lau WL, Pai A, Moe SM, Giachelli CM. Direct effects of phosphate on vascular cell function. Adv Chronic Kidney Dis. 2011;18(2):105\u201312.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"2421_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ki.2012.300","volume":"83","author":"GS Di Marco","year":"2013","unstructured":"Di Marco GS, Konig M, Stock C, Wiesinger A, Hillebrand U, Reiermann S, et al. High phosphate directly affects endothelial function by downregulating annexin II. Kidney Int. 2013;83(2):213\u201322.","journal-title":"Kidney Int"},{"issue":"11","key":"2421_CR20","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrneph.2013.111","volume":"9","author":"M Kuro-o","year":"2013","unstructured":"Kuro-o M. Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism. Nat Rev Nephrol. 2013;9(11):650\u201360.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"2421_CR21","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1046\/j.1523-1755.2003.00262.x","volume":"64","author":"R Santamaria","year":"2003","unstructured":"Santamaria R, Almaden Y, Felsenfeld A, Martin-Malo A, Gao P, Cantor T, et al. Dynamics of PTH secretion in hemodialysis patients as determined by the intact and whole PTH assays. Kidney Int. 2003;64(5):1867\u201373.","journal-title":"Kidney Int"},{"key":"2421_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev.me.37.020186.000443","volume":"37","author":"S Klahr","year":"1986","unstructured":"Klahr S, Slatopolsky E. Toxicity of parathyroid hormone in uremia. Annu Rev Med. 1986;37:71\u20138.","journal-title":"Annu Rev Med"},{"issue":"3","key":"2421_CR23","first-page":"151","volume":"7","author":"E Bogin","year":"1982","unstructured":"Bogin E, Levi J, Harary I, Massry SG. Effects of parathyroid hormone on oxidative phosphorylation of heart mitochondria. Min Electrolyte Metab. 1982;7(3):151\u20136.","journal-title":"Min Electrolyte Metab"},{"issue":"8160","key":"2421_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(80)90602-9","volume":"1","author":"T Drueke","year":"1980","unstructured":"Drueke T, Fauchet M, Fleury J, Lesourd P, Toure Y, Le Pailleur C, et al. Effect of parathyroidectomy on left-ventricular function in haemodialysis patients. Lancet. 1980;1(8160):112\u20134.","journal-title":"Lancet"},{"issue":"10","key":"2421_CR25","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1681\/ASN.V4101814","volume":"4","author":"K Amann","year":"1994","unstructured":"Amann K, Ritz E, Wiest G, Klaus G, Mall G. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol. 1994;4(10):1814\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"2421_CR26","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/sj.ki.5002241","volume":"71","author":"KR Neves","year":"2007","unstructured":"Neves KR, Graciolli FG, dos Reis LM, Graciolli RG, Neves CL, Magalhaes AO, et al. Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int. 2007;71(12):1262\u201370.","journal-title":"Kidney Int"},{"issue":"5","key":"2421_CR27","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1172\/JCI24140","volume":"115","author":"JS Shao","year":"2005","unstructured":"Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, Towler DA. Msx2 promotes cardiovascular calcification by activating paracrine wnt signals. J Clin Invest. 2005;115(5):1210\u201320.","journal-title":"J Clin Invest"},{"issue":"2","key":"2421_CR28","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ki.1993.64","volume":"43","author":"DJ Sherrard","year":"1993","unstructured":"Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, et al. The spectrum of bone disease in end-stage renal failure\u2013an evolving disorder. Kidney Int. 1993;43(2):436\u201342.","journal-title":"Kidney Int"},{"key":"2421_CR29","doi-asserted-by":"crossref","unstructured":"Su X, Hu L, You Z, Hu P, Wang L, Zhao B. A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2. Brief Bioinform. 2022;23(1).","DOI":"10.1093\/bib\/bbab526"},{"key":"2421_CR30","doi-asserted-by":"crossref","unstructured":"Zheng K, Zhang XL, Wang L, You ZH, Ji BY, Liang X et al. SPRDA: a link prediction approach based on the structural perturbation to infer disease-associated Piwi-interacting RNAs. Brief Bioinform. 2023;24(1).","DOI":"10.1093\/bib\/bbac498"},{"issue":"1","key":"2421_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12859-023-05309-w","volume":"24","author":"L Wong","year":"2023","unstructured":"Wong L, Wang L, You ZH, Yuan CA, Huang YA, Cao MY. GKLOMLI: a link prediction model for inferring miRNA-lncRNA interactions by using Gaussian kernel-based method on network profile and linear optimization algorithm. BMC Bioinformatics. 2023;24(1):188.","journal-title":"BMC Bioinformatics"},{"key":"2421_CR32","doi-asserted-by":"crossref","unstructured":"Wang L, Wong L, You Z. D H. AMDECDA: attention mechanism combined with Data Ensemble Strategy for Predicting CircRNA-Disease Association. IEEE Trans Big Data. 2013:1\u201311.","DOI":"10.1109\/TBDATA.2023.3334673"},{"issue":"1","key":"2421_CR33","doi-asserted-by":"publisher","first-page":"11862","DOI":"10.1038\/s41598-019-48263-5","volume":"9","author":"M Makino","year":"2019","unstructured":"Makino M, Yoshimoto R, Ono M, Itoko T, Katsuki T, Koseki A, et al. Artificial intelligence predicts the progression of diabetic kidney disease using big data machine learning. Sci Rep. 2019;9(1):11862.","journal-title":"Sci Rep"},{"issue":"3","key":"2421_CR34","doi-asserted-by":"publisher","first-page":"e1191","DOI":"10.1210\/clinem\/dgaa899","volume":"106","author":"YT Wu","year":"2021","unstructured":"Wu YT, Zhang CJ, Mol BW, Kawai A, Li C, Chen L, et al. Early Prediction of Gestational Diabetes Mellitus in the Chinese Population via Advanced Machine Learning. J Clin Endocrinol Metab. 2021;106(3):e1191\u2013e205.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 17","key":"2421_CR35","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12859-016-1334-9","volume":"17","author":"Y Yuan","year":"2016","unstructured":"Yuan Y, Shi Y, Li C, Kim J, Cai W, Han Z, et al. DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations. BMC Bioinformatics. 2016;17(Suppl 17):476.","journal-title":"BMC Bioinformatics"},{"key":"2421_CR36","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.3389\/fimmu.2018.03099","volume":"9","author":"Q Hu","year":"2018","unstructured":"Hu Q, Gong W, Gu J, Geng G, Li T, Tian R, et al. Plasma microRNA profiles as a potential biomarker in differentiating adult-onset still\u2019s Disease from Sepsis. Front Immunol. 2018;9:3099.","journal-title":"Front Immunol"},{"issue":"19","key":"2421_CR37","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1093\/bioinformatics\/btaa596","volume":"36","author":"Y Shi","year":"2020","unstructured":"Shi Y, Guo Z, Su X, Meng L, Zhang M, Sun J, et al. DeepAntigen: a novel method for neoantigen prioritization via 3D genome and deep sparse learning. Bioinformatics. 2020;36(19):4894\u2013901.","journal-title":"Bioinformatics"},{"issue":"6","key":"2421_CR38","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.semnephrol.2007.09.005","volume":"27","author":"P Devarajan","year":"2007","unstructured":"Devarajan P. Proteomics for biomarker discovery in acute kidney injury. Semin Nephrol. 2007;27(6):637\u201351.","journal-title":"Semin Nephrol"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-024-02421-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-024-02421-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-024-02421-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T11:12:07Z","timestamp":1707131527000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-024-02421-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,5]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2421"],"URL":"https:\/\/doi.org\/10.1186\/s12911-024-02421-6","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,5]]},"assertion":[{"value":"17 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All methods were carried out in accordance with guidelines and regulations of Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine.All experimental protocols were approved by Ethics Committee of Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine.All the patients agreed and signed the Informed Consent Form with Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The results presented in this article have not been published previously. The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}